Predictive Oncology Inc. (NASDAQ: POAI) Notes Indications of Interest in Medical Division; Regains Nasdaq Price Compliance
Several parties have indicated interest in potential acquisition of POAI’s Skyline Medical division The division has seen recent success with growing sales of its patented, FDA-approved STREAMWAY System POAI also regained compliance with Nasdaq’s minimum bid price requirement Predictive Oncology Inc. (NASDAQ: POAI), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has revealed that several parties have indicated interest in the potential acquisition of Skyline Medical, the division of the company that produces and sells the STREAMWAY System (http://ibn.fm/fjuZr). The patented, FDA-approved STREAMWAY System is the first truly continuous, direct-to-drain fluid disposal system designed specifically for…